21 C
Bucharest
May 19, 2022
Valahia.News
Image default
International News News

The Americans Presented Remdesivir as the Antiviral Drug against COVID-19, Now Looking for Vaccine

Dr. Anthony Fauci, the famous virologist from the US, announced that the drug with definite results against COVID-19 was found.

The antiviral drug Remdesivir belongs to the biotechnology company Gilead Sciences and may become the standard treatment for COVID-19, at least in the United States. The clinical study, conducted with the support of the National Institute of Allergy and Infectious Diseases (NIAID) in the US, shows that Remdesivir has a clear-cut, significant positive effect in diminishing the time to recover for patients infected with Coronavirus. Thus, preliminary results show that patients who received Remdesivir had a 31% faster recovery period than patients who received a placebo. Moreover, the mortality rate was 8.0% in the group that received Remdesivir, compared to 11.6% for the placebo group.

Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), says the findings are “significant”, anticipating that “this will be the standard for treatment“.

On top of that, Donald Trump has launched an acceleration program called “Operation Warp Speed” to develop a Coronavirus vaccine. The main purpose of this program is to reduce the period of development of a vaccine by eight months and it’s based on a collaboration between private pharmaceutical companies and civilian and military governmental agencies.

The program will start with rapid animal testing of the world’s most promising experimental vaccines, from almost 100 trial vaccines developed so far, followed by human clinical trials.

Photo source: Coronavirus.gov

Related posts

WUHAN Coronavirus COVID-19 – what you need to know

Valahia.news

Why Romanians Will Avoid Greece from July 15 and Choose Turkey or Bulgaria

Valahia.news

Why Do Romanian Officials Ask for Immunity for the Acquisitions Made During COVID-19 Pandemic?

Valahia.news

Leave a Comment